ADVERTISEMENT

'Buy' EPL, 'Hold' SRF Among Others Lists ICICI Securities Ahead Of Specialty Chemicals Q1 Results

Specialty Chemicals' Ebitda on a low base, could grow 9.8% YoY/ dip 5.8% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemicals, and Archean likely outperforming, adds ICICI Securities

<div class="paragraphs"><p>ICICI Securities' specialty chemicals coverage universe’s revenue to grow 10% YoY/ flat QoQ in Q1 FY26E on a low base alongside a gradual demand recovery. (photo Source: Freepik)</p></div>
ICICI Securities' specialty chemicals coverage universe’s revenue to grow 10% YoY/ flat QoQ in Q1 FY26E on a low base alongside a gradual demand recovery. (photo Source: Freepik)
Specialty Chemicals' Ebitda on a low base, could grow 9.8% YoY/ dip 5.8% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemicals, and Archean likely outperforming.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit